Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,706Revenue $M96.5Net Margin (%)-157.0Z-Score6.2
Enterprise Value $M4,709EPS $-0.3Operating Margin %-173.0F-Score3
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-153.1Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %4.4Quick Ratio1.9Cash flow > EarningsY
Price/Sales51.65-y EBITDA Growth Rate %27.0Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-10.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-15.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M434ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerupGuruDate Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKMario Gabelli 2014-09-30 Reduce$8.19 - $9.46
($8.79)
$ 10.8423%Reduce -26.67%11,000
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 10.8424%Reduce -84.24%235,600
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 10.8424%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 10.8435%New holding, 745000 sh.745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 10.84170%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 10.84369%Add 962%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 10.84414%Reduce -90%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
OPK George Soros 2014-09-30235,6000.050.02
OPK Mario Gabelli 2014-09-3011,00000-26.67%
Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-22Buy28,000$10.523.04view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-21Buy41,700$10.235.96view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-20Buy45,000$10.117.22view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-16Buy25,000$10.018.29view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-15Buy44,000$108.4view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-13Buy25,000$10.156.8view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-09Buy9,200$10.17.33view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-08Buy22,300$10.038.08view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-06Buy26,000$9.929.27view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-01-02Buy28,000$9.929.27view

Press Releases about OPK :

    Quarterly/Annual Reports about OPK:

    News about OPK:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
    Weekly CEO Buys Highlight: LTRPA, ENH, BH, OPK, CPTA Dec 28 2014 
    Self-Made Billionaire Believes Drone Aviation Holding Corp. (DRNE) Will Be 2015's Best-Performing Dr Dec 16 2014 
    Why Opko Health Is a Better Investment Than Apple Dec 02 2014 
    Weekly CEO Buys Highlight: APD, SFXE, HTZ, OPK, TRUE Nov 26 2014 
    Weekly CEO Buys Highlight: AM, UPLD, MEMP, X, OPK Nov 17 2014 
    Weekly CEO Buys Highlight: SONS, OPK, AKS, ARAY, ENH Nov 09 2014 
    Weekly CEO Buys Highlight: JMP, SONS, OPK, ARAY, CBNJ Nov 04 2014 
    Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 

    More From Other Websites
    OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 14 2015
    OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno... Jan 13 2015
    OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno... Jan 13 2015
    OPKO Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    OPKO Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    Lottery ticket sector of 2015 Dec 22 2014
    Pfizer Partners With Young Little Known Biotech For Products With Huge Potential Value Dec 18 2014
    Pfizer Ponies Up to Develop Long-acting Growth Hormone Dec 16 2014
    Pfizer, OPKO Health partner on growth-hormone treatment Dec 15 2014
    Opko Health Inks Pfizer License Pact Dec 15 2014
    Pfizer, OPKO Health Partner on Growth-Hormone Treatment Dec 15 2014
    Pfizer Licenses Opko's Long-Acting Growth Hormone Dec 15 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 15 2014
    Cramer's Mad Dash: Twitter gets a lift Dec 15 2014
    Opko Health Soars 13% On Pfizer hGh-CTP News Dec 15 2014
    OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP) Dec 15 2014
    OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP) Dec 15 2014
    Tiger Media Announces Agreement to Acquire Interactive Data, LLC Dec 15 2014
    OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
    OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK